Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$145.54 - $178.83 $66,802 - $82,082
-459 Reduced 22.63%
1,569 $272,000
Q1 2024

May 02, 2024

SELL
$165.67 - $199.94 $5,798 - $6,997
-35 Reduced 1.7%
2,028 $343,000
Q4 2023

Feb 09, 2024

SELL
$151.44 - $200.09 $15,144 - $20,009
-100 Reduced 4.62%
2,063 $407,000
Q3 2023

Nov 03, 2023

SELL
$167.14 - $192.77 $268,259 - $309,395
-1,605 Reduced 42.6%
2,163 $376,000
Q2 2023

Jul 17, 2023

SELL
$160.94 - $186.23 $4,023 - $4,655
-25 Reduced 0.66%
3,768 $648,000
Q1 2023

Apr 20, 2023

BUY
$145.48 - $175.02 $58,482 - $70,358
402 Added 11.85%
3,793 $631,000
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $76,454 - $91,805
-583 Reduced 14.67%
3,391 $497,000
Q3 2022

Oct 14, 2022

BUY
$148.29 - $182.55 $414,767 - $510,592
2,797 Added 237.64%
3,974 $589,000
Q2 2022

Jul 18, 2022

BUY
$155.97 - $200.09 $1,403 - $1,800
9 Added 0.77%
1,177 $202,000
Q4 2021

Jan 28, 2022

SELL
$193.69 - $247.03 $20,724 - $26,432
-107 Reduced 8.39%
1,168 $285,000
Q2 2021

Aug 10, 2021

SELL
$155.9 - $187.99 $2,650 - $3,195
-17 Reduced 1.32%
1,275 $238,000
Q1 2021

May 06, 2021

BUY
$144.0 - $169.39 $186,048 - $218,851
1,292 New
1,292 $203,000
Q4 2020

Feb 04, 2021

SELL
$157.07 - $174.35 $197,751 - $219,506
-1,259 Closed
0 $0
Q3 2020

Oct 28, 2020

BUY
$137.1 - $165.37 $172,608 - $208,200
1,259 New
1,259 $208,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $29,888 - $35,916
-377 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $31,479 - $35,147
377 New
377 $35,000
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $31,960 - $35,680
-400 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $28,604 - $33,876
400 New
400 $33,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.